In November 2024 NICE, in collaboration the British Thoracic Society (BTS) and the Scottish Intercollegiate Guidelines Network (SIGN), released guidance NG245.
In this podcast Fiona Mosgrove (PCRS Education lead) and Tom Fardon (Consultant Physician) discuss asthma biologics and how they can support effective severe asthma care.
Are you struggling to persuade your Integrated Care Board (ICB) to fund FeNO testing? With the new BTS/NICE/SIGN asthma guideline recommending FeNO for asthma diagnostic testing, this can create quite a challenging for primary care providers.
The Medicines and Healthcare products Regulatory Agency (MHRA) has put out a reminder for healthcare professionals and patients with asthma that overuse of blue inhalers (short-acting beta 2 agonists or SABAs), without use of a preventer inhaler, may lead to worsening symptoms or serious asthma a
Join Dr Sanjeev Rana and Dr Katherine Hickman on Wednesday 30th April from 19:00 for a focused, practical session offering clear, evidence-based guidance on when to use FeNO testing to support asthma diagnosis.
Childhood asthma is the most common chronic disease in childhood, with a prevalence of 10.2% in 2018. However, there is evidence of over-and under diagnosis in about 30% in mixed populations of adults and children and young people (CYP).
The Primary Care Respiratory Society (PCRS) and Asthma + Lung UK call for urgent action to address the growing number of online pharmacies selling salbutamol inhalers without appropriate medical oversight.
The webinar will be held on Friday 9 May 2025 at 19:00 for 45 minutes. Chaired by Katherine Hickman (our PCRS Executive Chair), she and guest speakers, Deborah Leese and Marieke Strange, will focus on:
In this episode of the PCRS Podcast our Executive Chair, Dr Katherine Hickman, is joined by Dr Llinos Jones, Consultant Respiratory Physician with a specialist interest in asthma.
The Allergy Academy from King’s College London is collaborating with the paediatric and adult severe asthma centres to provide a panel of national and international experts to best inform practice.
2024 marked a pivotal change in the management of asthma in the UK with the publication of a joint British Thoracic Society (BTS), National Institute for Health and Care Excellence (NICE) and Scottish Intercollegiate Guidelines Network (SIGN) guideline.
Over the past 20-years, there has been an increased focus on the use of newer biologic medication in people with severe asthma that is not controlled with usual asthma medication.
The start of a new year is an ideal time to support people to consider small ways to begin working towards a healthy lifestyle.
The National Review of Asthma Deaths (NRAD) came out a decade ago, yet as a nation, we still have the highest asthma death rate in Europe - four times that of Italy or the Netherlands. This is unsurprising, considering many patients still rely on their blue inhalers alone.
The webinar will be held on Wednesday 15th January 2025 at 19:00 for 30 minutes.